Understanding the pathological mechanisms underpinning functional impairments in schizophrenia: Gamma oscillations versus mismatch negativity (MMN) as mediating factors

Clinical Neurophysiology

Volumn 124, Issue 11, 2013, Pages 2075-2076

  Harms, Lauren R ^a   Michie, Patricia T ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE;

ATTENTION; BRAIN ELECTROPHYSIOLOGY; EDITORIAL; ENDOPHENOTYPE; EVENT RELATED POTENTIAL; EXECUTIVE FUNCTION; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GAMMA RHYTHM; HUMAN; INTERNEURON; MISMATCH NEGATIVITY; NERVE CELL INHIBITION; NONHUMAN; OSCILLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; TASK PERFORMANCE; WORKING MEMORY;

EID: 84885839691     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2013.05.022     Document Type: Editorial

References (31)

1. Ballesteros A., Summerfelt A., Du X., Jiang P., Chiappelli J., Tagamets M., et al. Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol 2013, 124:2209-2215.
2. Basar-Eroglu C., Brand A., Hildebrandt H., Karolina Kedzior K., Mathes B., Schmiedt C. Working memory related gamma oscillations in schizophrenia patients. Int J Psychophysiol 2007, 64:39-45.
3. Basar-Eroglu C., Schmiedt-Fehr C., Mathes B., Zimmermann J., Brand A. Are oscillatory brain responses generally reduced in schizophrenia during long sustained attentional processing?. Int J Psychophysiol 2009, 71:75-83.
4. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010, 13:76-83.
5. Carlen M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 2012, 17:537-548.
6. Carpenter W.T., Koenig J.I. The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology 2008, 33:2061-2079.
7. Carter C.S. Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia. Schizophr Bull 2005, 31:810-815.
8. Cho R.Y., Konecky R.O., Carter C.S. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A 2006, 103:19878-19883.
9. Ehrlichman R.S., Maxwell C.R., Majumdar S., Siegel S.J. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice. J Cogn Neurosci 2008, 20:1403-1414.
10. Fries P., Reynolds J.H., Rorie A.E., Desimone R. Modulation of oscillatory neuronal synchronization by selective visual attention. Science 2001, 291:1560-1563.
11. Gonzalez-Burgos G., Lewis D.A. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 2008, 34:944-961.
12. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996, 153:321-330.
13. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006, 67:e12.
14. Gruber T., Muller M.M., Keil A., Elbert T. Selective visual-spatial attention alters induced gamma band responses in the human EEG. Clin Neurophysiol 1999, 110:2074-2085.
15. Haenschel C., Bittner R.A., Waltz J., Haertling F., Wibral M., Singer W., et al. Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. J Neurosci 2009, 29:9481-9489.
16. Harvey P.D., Keefe R.S. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 2001, 158:176-184.
17. Javitt D.C., Steinschneider M., Schroeder C.E., Arezzo J.C. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A 1996, 93:11962-11967.
18. Javitt D.C., Zukin S.R., Heresco-Levy U., Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr Bull 2012, 38:958-966.
19. Kreitschmann-Andermahr I., Rosburg T., Demme U., Gaser E., Nowak H., Sauer H. Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Brain Res Cogn Brain Res 2001, 12:109-116.
20. Leifker F.R., Bowie C.R., Harvey P.D. Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res 2009, 115:82-87.
21. Mintz J., Kopelowicz A. CUtLASS confirms CATIE. Arch Gen Psychiatry 2007, 64:978. author reply 9-80.
22. Minzenberg M.J., Firl A.J., Yoon J.H., Gomes G.C., Reinking C., Carter C.S. Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia. Neuropsychopharmacology 2010, 35:2590-2599.
23. Owen J.B., Butterfield D.A. Measurement of oxidized/reduced glutathione ratio. Methods Mol Biol 2010, 648:269-277.
24. Pesaran B., Pezaris J.S., Sahani M., Mitra P.P., Andersen R.A. Temporal structure in neuronal activity during working memory in macaque parietal cortex. Nat Neurosci 2002, 5:805-811.
25. Roux F., Wibral M., Mohr H.M., Singer W., Uhlhaas P.J. Gamma-band activity in human prefrontal cortex codes for the number of relevant items maintained in working memory. J Neurosci 2012, 32:12411-12420.
26. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702.
27. Tikhonravov D., Neuvonen T., Pertovaara A., Savioja K., Ruusuvirta T., Naatanen R., et al. Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats. Brain Res 2008, 1203:97-102.
28. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010, 11:100-113.
29. Umbricht D., Koller R., Vollenweider F.X., Schmid L. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 2002, 51:400-406.
30. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., Javitt D.C. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 2000, 57:1139-1147.
31. Womelsdorf T., Fries P., Mitra P.P., Desimone R. Gamma-band synchronization in visual cortex predicts speed of change detection. Nature 2006, 439:733-736.